Roswell Park Comprehensive Cancer Center

June 28, 2022

Mary Lynn McPherson, PharmD, BCPS, FAAHPM, and Amy A. Case, MD, FAAHPM, argue that buprenorphine should play a larger role in cancer-related pain management because of its unique pharmacology and consequent safety profile.

May 26, 2022

Oncology nurses present their experiences treating patients with sotorasib in the phase 1/2 CodeBreaK 100 trial and optimal symptom management strategies to improve patient outcomes with the drug.

April 22, 2022

Advocacy and opposition continue to grow regarding the National Organization of Nurse Practitioner Faculties’ goal of requiring the Doctor of Nursing Practice degree (DNP) for entry-level nurse practitioners.

April 15, 2022

Longer follow-up data from the phase 1/2 CodeBreaK 100 trial show that patients with KRAS G12C–mutant non–small cell lung cancer experienced improved prolonged overall survival and encouraging response rates with sotorasib.

February 10, 2022

Experts from Roswell Park developed a dosing guide for the prescription of buprenorphine as treatment for chronic pain.

September 30, 2021

With education one of the cornerstones of its mission, Roswell Park Comprehensive Cancer Center is pleased to announce that its Nurse Residency Program has achieved Accreditation with Distinction from the American Nurses Credentialing Center (ANCC).